Drug Payouts: Pharma giant caught paying doctors

Drug giant Bristol-Myers Squibb (annual sales: $17.9bn) is “proud of its commitment to conduct business with the highest standards of integrity in its mission to extend and enhance human life”, according to a spokesman.

Strange, then, that it has just been handed a whopping $515m fine for mis-selling drugs, inducing doctors to prescribe drugs inappropriately, and setting fraudulent prices on some of its products.

The company has been caught making illegal payments to doctors as an inducement to get them to buy their drugs.  Doctors also received ‘consulting fees’ to sit on supposed advisory boards and programmes, some of which involved necessary trips to luxury locations where, as part of the fact-gathering exercise, expensive wines and fine foods had to be consumed.

Meanwhile, the company was paying retail and wholesale pharmacies to buy its drugs.
It was also encouraging doctors to prescribe its antipsychotic drug Abilify (aripiprazole) to children when it had been licensed for use only to adults.

Must be part of that mission to extend and enhance profits, sorry, human life.

(Source:  British Medical Journal, 2007; 335: 742-3).

Click here to receive health news by email.

Related WDDTY Content

Selling drugs - For rx, read ra-ra

Sex sells, as has occurred to drug companies that are now recruiting cheerleaders, those scantily clad pom-pom girls at American football and basket-b...

Drugs firm puts on the pressure to stop research

The drug manufacturer Bristol-Myers Squibb has been taken to task by The Lancet, the medical journal, for attempting to stop an independent trial into...

Health Advice

Visit our sub sites on How you beat asthma...

Antipsychotic: Eli Lilly suppresses data that reveals drug’s danger, papers claim

Sensitive documents that suggest the drug maker Eli Lilly has been suppressing vital safety information about its best-selling antipsychotic Zyprexa (...

Popular diabetes drug causes fatal heart failure

One of the most popular drugs for type II diabetes – with annual sales of around $2.5bn – increases the risks of heart failure and death.

Statins: Are they the great drug con?

Cholesterol-lowering statin drugs are some of the most widely used in the world, with annual sales in the USA alone of $15.5bn – and they may also be...